Mark D. Rothmann

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• The University of Texas MD Anderson Cancer Center14.9%
• Harvard University9.5%
• Center for Drug Evaluation and Research9.3%
• Inserm8.2%
• United States Food and Drug Administration7.3%
• Sun Yat-sen University6.6%
• Other44.3%

Fields

• Medicine67%
• Biochemistry, Genetics and Molecular Biology19.3%
• Mathematics3.4%
• Chemistry1.9%
• Pharmacology, Toxicology and Pharmaceutics1.6%
• Computer Science1.4%
• Other5.3%

Topics

• Chronic Myeloid Leukemia Treatments14.2%
• HER2/EGFR in Cancer Research9.5%
• Chronic Lymphocytic Leukemia Research9.1%
• Ubiquitin and proteasome pathways6.9%
• Monoclonal and Polyclonal Antibodies Research6.7%
• Protein Degradation and Inhibitors6.5%
• Other47.1%